Clinical Challenges: Sequencing in Metastatic, HER2-Positive Breast Cancer

Data have narrowed first- and second-line choices, but decisions must be tailored to the patient

Related Keywords

Delaware ,United States ,Kellye Mccann ,Shridar Ganesan ,Leah Lawrence ,Rutgers Cancer Institute Of New Jersey ,National Comprehensive Cancer Network ,Rutgers Cancer Institute ,